Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease

scientific article

Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00415-012-6828-4
P698PubMed publication ID23299623
P5875ResearchGate publication ID234089265

P50authorJaroslav RosenbergerQ45746974
Jitse P van DijkQ50634549
P2093author name stringJohan W Groothoff
Matej Skorvanek
Zuzana Gdovinova
Iveta Nagyova
Radka Ghorbani Saeedian
Martina Krokavcova
P2860cites workChronic fatigue syndrome--a clinically empirical approach to its definition and studyQ24536313
“Mini-mental state”Q25938989
The hospital anxiety and depression scaleQ27860968
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleQ28256570
Parkinsonism: onset, progression, and mortalityQ28259134
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchQ29547257
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 casesQ29614910
Fatigue in levodopa-naive subjects with Parkinson diseaseQ30434565
Levodopa improves physical fatigue in Parkinson's disease: A double‐blind, placebo‐controlled, crossover studyQ30540639
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatientsQ34413083
Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment?Q34556713
Depression rating scales in Parkinson's disease: critique and recommendationsQ34578187
Fatigue in Parkinson's disease: a reviewQ36667874
Anxiety rating scales in Parkinson's disease: critique and recommendationsQ37269003
Fatigue in older adults: an early indicator of the aging process?Q37741724
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's diseaseQ37749714
Scales to assess sleep impairment in Parkinson's disease: critique and recommendationsQ37798777
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.Q37808677
Fatigue in Parkinson's diseaseQ37884077
Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of NeurologyQ39891478
The Parkinson fatigue scale.Q40458495
Pergolide mesilate may improve fatigue in patients with Parkinson's diseaseQ40993494
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction.Q42872557
Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatmentQ43057272
An exploratory study of activity in veterans with Parkinson's diseaseQ45171892
Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson's diseaseQ48006994
Gender-related differences in the burden of non-motor symptoms in Parkinson's diseaseQ48264764
Towards an understanding of fatigue in Parkinson diseaseQ48298647
Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's diseaseQ48336115
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's diseaseQ48398056
Non-recognition of depression and other non-motor symptoms in Parkinson's diseaseQ48660726
Exacerbated physical fatigue and mental fatigue in Parkinson's diseaseQ48681750
Fatigue in early Parkinson's disease. Minor inconvenience or major distress?Q48729304
Fatigue in patients with Parkinson's diseaseQ48769057
Sleep, excessive daytime sleepiness and fatigue in Parkinson's diseaseQ48878240
Impact of fatigue on quality of life in patients with Parkinson's disease.Q51893037
Is fatigue an independent and persistent symptom in patients with Parkinson disease?Q51935419
The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigueQ52017423
Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease.Q53175429
Fatigue in Parkinson's diseaseQ70514581
Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trialQ80733175
Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS)Q83318643
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)1554-1561
P577publication date2013-01-09
P1433published inJournal of NeurologyQ6295649
P1476titleClinical determinants of primary and secondary fatigue in patients with Parkinson's disease
P478volume260

Reverse relations

cites work (P2860)
Q64864842Q64864842
Q55073609Acupuncture in the treatment of fatigue in Parkinson's disease: A pilot, randomized, controlled, study.
Q62719741Depression, Apathy, Anhedonia, and Fatigue in Parkinson’s Disease
Q38124676Fatigue in healthy and diseased individuals
Q36559298Risk Factors of Fatigue in Idiopathic Parkinson's Disease in a Polish Population
Q92584079The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management
Q47721519The associations between fatigue, apathy, and depression in Parkinson's disease

Search more.